HEALTHYWAY INC (02587) announced its interim results for 2025, reporting revenue of RMB 518 million, representing a 15.3% year-over-year decline. The company recorded a profit attributable to equity shareholders of RMB 7.066 million, compared to a loss of RMB 55.818 million in the same period last year. Basic earnings per share stood at RMB 0.01.